Evgen Pharma plc (EVG) Ordinary 0.25p
Evgen Pharma plc Ordinary 0.25p
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
- Add to watchlist
- Create an alert
- This stock can be held in a
Evgen Pharma plc Ordinary 0.25p
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
Evgen Pharma plc Ordinary 0.25p
- Type:
- Miscellaneous
- Shareholder action required:
- Yes
- Status:
- Update Pending
Business summary
Evgen Pharma plc is a United Kingdom-based clinical-stage drug development company. The Company is focused on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. The Company's core technology is Sulforadex, which is a method for synthesizing and stabilizing the naturally occurring compound sulforaphane and novel proprietary analogues based on sulforaphane. Its asset, SFX-01, is a composition of synthetic sulforaphane and alpha-cyclodextrin and has undergone clinical trials for oestrogen-positive metastatic breast cancer. SFX-01 exploits sulforaphane's activity in three separate biochemical pathways, such as inhibition of STAT3 and SHP2, of importance in controlling cancers metastases, and up-regulation of Nrf2, a pathway of significance in several different diseases. Its pipeline includes breast cancer, glioblastoma, hematological malignancies, and analogues. It also has a licensing in neurodevelopmental disorders and schizophrenia.
Contact details
Important dates
General stock information
- EPIC:
- EVG
- ISIN:
- GB00BSVYN304
- Market cap:
- £3.31 million
- Shares in issue:
- 427.35 million
- Sector:
- Pharmaceuticals & Biotechnology
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.